InsiderTrades.com logo

Yu-Hsin Lin Biography and Net Worth

Chairman & CEO of Belite Bio
  • Phone
  • Email
  • Website


Dr. Tom Lin (Yu-Hsin Lin) is the Founder, Chairman, and Chief Executive Officer of Belite Bio. Dr. Lin is also the Founder of Lin BioScience, Inc. (TPEx: 6696), our ultimate controlling shareholder.  Prior to founding Belite Bio, Dr. Lin was executive officer of several biotech companies, including Lin BioScience, Inc. Dr. Lin received his master’s degree in Medicine and PhD in Medicine from University of Sydney, and his MBA from Columbia University, London Business School, and University of Hong Kong.

What is Yu-Hsin Lin's net worth?

The estimated net worth of Yu-Hsin Lin is at least $17.61 million as of September 4th, 2026. Dr. Lin owns 96,134 shares of Belite Bio stock worth more than $17,607,903 as of September 10th. This net worth approximation does not reflect any other investments that Dr. Lin may own. Learn More about Yu-Hsin Lin's net worth.

How do I contact Yu-Hsin Lin?

The corporate mailing address for Dr. Lin and other Belite Bio executives is , , . Belite Bio can also be reached via phone at 858-246-6240 and via email at [email protected]. Learn More on Yu-Hsin Lin's contact information.

Has Yu-Hsin Lin been buying or selling shares of Belite Bio?

During the last ninety days, Yu-Hsin Lin has sold $19,148,581.60 in shares of Belite Bio stock. Most recently, Yu-Hsin Lin sold 26,000 shares of the business's stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $196.56, for a transaction totalling $5,110,560.00. Following the completion of the sale, the chief executive officer now directly owns 70,134 shares of the company's stock, valued at $13,785,539.04. Learn More on Yu-Hsin Lin's trading history.

Who are Belite Bio's active insiders?

Belite Bio's insider roster includes Wan-Shan Chen (Director), Hao-Yuan Chuang (CFO), Yu-Hsin Lin (Chairman & CEO), Nathan Mata (Chief Scientific Officer), and Hendrik Scholl (Chief Medical Officer). Learn More on Belite Bio's active insiders.

Are insiders buying or selling shares of Belite Bio?

In the last year, insiders at the sold shares 21 times. They sold a total of 214,728 shares worth more than $39,424,925.07. The most recent insider tranaction occured on September, 8th when CEO Yu-Hsin Lin sold 26,000 shares worth more than $5,110,560.00. Insiders at Belite Bio own 13.3% of the company. Learn More about insider trades at Belite Bio.

Information on this page was last updated on 9/8/2026.

Yu-Hsin Lin Insider Trading History at Belite Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/8/2026Sell26,000$196.56$5,110,560.0070,134View SEC Filing Icon  
9/4/2026Sell74,435$187.71$13,972,193.8596,134View SEC Filing Icon  
8/12/2026Sell365$180.35$65,827.75170,569View SEC Filing Icon  
4/9/2026Sell9,200$181.45$1,669,340.00170,934View SEC Filing Icon  
See Full Table

Yu-Hsin Lin Buying and Selling Activity at Belite Bio

This chart shows Yu-Hsin Lin's buying and selling at Belite Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Belite Bio Company Overview

Belite Bio logo
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company's lead product candidate is LBS-008 (Tinlarebant), an orally administered once-a-day tablet for maintaining the health and integrity of retinal tissues in autosomal recessive Stargardt disease and geographic atrophy patients. It is also developing LBS-009, an anti-retinol binding protein 4 oral therapy that is in the preclinical development phase targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.
Read More

Today's Range

Now: $183.16
Low: $181.80
High: $191.30

50 Day Range

MA: $160.55
Low: $146.63
High: $193.61

2 Week Range

Now: $183.16
Low: $64.80
High: $200.00

Volume

214,121 shs

Average Volume

214,515 shs

Market Capitalization

$7.38 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A